Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document

Previous Fragment    Next Fragment

Notice given 6 November 2003

2362  Senator Nettle: To ask the President of the Senate—

(1) When did, the Joint House Department commission the company One Planet Solutions to work on an early childhood centre for Parliament House.

(2) How was the company selected.

(3) Who is the company required to consult in the course of fulfilling its contract.

(4) What is the timeline for the project, and what is the expected date for commencement.

(5) Have any decisions been made, and, if so, by whom, about: (a) where the centre will be located; (b) who will be permitted to use the centre; (c) who will operate the centre; (d) what the hours and days of operation will be; and (d) whether fees are to be charged and, if so, how these will be determined.

2363  Senator Nettle: To ask the Minister representing the Prime Minister—With reference to a letter dated 27 October 2003 referred to in the Council of Australian Governments (COAG) Communiqué, written by the Prime Minister to the members of the COAG in the lead-up to the November 2000 COAG meeting:

(1) Can the names and positions be provided of the ‘senior COAG officials’ who drafted the amendments to the National Competition Policy Arrangements passed at the November 2000 COAG meeting.

(2) Can names and positions be provided of the ‘senior COAG officials’ who were given the task of consulting with the National Competition Council about its forward work program, activities, assessments, communications, guidance and interpretation and helping to formulate ‘appropriate assessment benchmarks’.

(3) (a) How was this team (or these teams, if there is more than one team) of officials chosen and by whom; and (b) to whom do these officials report. 

2364  Senator Nettle: To ask the Minister representing the Minister for Health and Ageing— With reference to the recently completed Guidelines for Medication Management in Residential Aged Care Facilities, which states on page 5, ‘[Consumer Medicine Information] should be provided to residents who are administering their own medications as an aid to counselling about their medicines.  Where residents are not administering their own medications, CMI should be available to either residents or their carers’:

(1) Do residential aged care facilities have to comply with the guidelines in order to receive Commonwealth accreditation and/or funding; if so, how is compliance monitored; if not, why not.

(2) What role do these guidelines have in the accreditation and auditing process for residential aged care facilities.

(3) Are any other measures in place to ensure that all carers in residential aged care facilities have access to and knowledge of consumer medicine information sheets.